In the latest Health Policy Outlook AEI health expert Scott Gottlieb, MD explains how a previously obscure government advisory panel now wields tremendous powers to decide which preventive health care services public and private insurance will cover.

For many years, community financial institutions have been denied fair and equal access to the secondary market. Banks prosper by making prudent loans with an adequate return and maintaining a reasonable cost structure. Today 97 percent of our banks are community banks and they are increasingly finding this business model under siege.

The problem of proxy access to the corporation’s ballot has been one that the Securities and Exchange Commission (SEC) has struggled with for a long time.

Rapid growth in the P2P industry has given rise to concerns over appropriate regulation of this alternative form of lending.

In a just-published op-ed in the New York Times, American Enterprise Institute (AEI) international health economist Roger Bate highlights a better way to fight fake pharmaceuticals while still giving poor Americans access to less costly drugs from online pharmacies.

The donor community indirectly and African governments directly are undermining drug quality through their push for local production.

A bill in the House could tie your doctor's hands.

The Medicaid drug program wasted $329 million nationwide in 2009 from states all too frequently reimbursing for a version of a drug that is more costly than another product with the exact same active ingredient, dose, form and bottle size.